Conformationally constrained histidines in the design of peptidomimetics: strategies for the χ-space control. 2011

Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
Department of Pharmaceutical Sciences, University of Chieti-Pescara "G. d'Annunzio", Via dei Vestini 31, 66100 Chieti, Italy.

A successful design of peptidomimetics must come to terms with χ-space control. The incorporation of χ-space constrained amino acids into bioactive peptides renders the χ(1) and χ(2) torsional angles of pharmacophore amino acids critical for activity and selectivity as with other relevant structural features of the template. This review describes histidine analogues characterized by replacement of native α and/or β-hydrogen atoms with alkyl substituents as well as analogues with α, β-didehydro unsaturation or C(α)-C(β) cyclopropane insertion (ACC derivatives). Attention is also dedicated to the relevant field of β-aminoacid chemistry by describing the synthesis of β(2)- and β(3)-models (β-hHis). Structural modifications leading to cyclic imino derivatives such as spinacine, aza-histidine and analogues with shortening or elongation of the native side chain (nor-histidine and homo-histidine, respectively) are also described. Examples of the use of the described analogues to replace native histidine in bioactive peptides are also given.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D006639 Histidine An essential amino acid that is required for the production of HISTAMINE. Histidine, L-isomer,L-Histidine,Histidine, L isomer,L-isomer Histidine
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D057786 Peptidomimetics Compounds that are designed to mimic the 3D structure of a natural peptide or protein. Peptidomimetic

Related Publications

Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
December 2011, Chembiochem : a European journal of chemical biology,
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
January 2006, Current medicinal chemistry,
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
January 2009, The Journal of organic chemistry,
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
November 2001, Chembiochem : a European journal of chemical biology,
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
September 2023, Peptide science (Hoboken, N.J.),
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
September 2016, Chemistry (Weinheim an der Bergstrasse, Germany),
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
November 2021, ACS medicinal chemistry letters,
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
January 1991, Methods in enzymology,
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
August 1998, Bioorganic & medicinal chemistry letters,
Azzurra Stefanucci, and Francesco Pinnen, and Federica Feliciani, and Ivana Cacciatore, and Gino Lucente, and Adriano Mollica
September 2017, European journal of medicinal chemistry,
Copied contents to your clipboard!